Insider buying
~$54K9,530 sh @ $5.63
Traded Dec 12, 2025 · filed 4 days later
An Ultralife director paid $54K out of pocket for Ultralife shares. 3 other people at Ultralife bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 19, 2025 · Filed Nov 21, 2025
An Ultralife director paid $268K out of pocket for Ultralife shares. 3 other people at Ultralife bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$267,915
Shares × reported transaction price
$100K–$500K
+4.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
1 day after results of Nov 18, 2025, 111 days before results of Mar 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $5.06 on Nov 19, 2025, 23% above its 52-week low and 45% below its high, after a 26% drop over the previous 30 trading days
52-week range $4.13 (Apr 21, 2025) to $9.13 (Jul 21, 2025), 19% of the way up, from 250 adjusted closes. 30 trading days earlier: $6.84 on Oct 8, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.4% | +1.7% | −3.1% |
| 30 days | +4.8% | +3.2% | +1.6% |
| 90 days | +3.0% | +2.0% | +1.0% |
| 180 days | +21.6% | +12.2% | +9.4% |
Past results only. Not a forecast.
Insider buying
Traded Dec 12, 2025 · filed 4 days later
An Ultralife director paid $54K out of pocket for Ultralife shares. 3 other people at Ultralife bought some too, in the same month.
Insider buying
Traded Dec 15, 2025 · filed 1 day later
An Ultralife director paid $84K out of pocket for Ultralife shares. 3 other people at Ultralife bought some too, in the same month.
Insider buying
Traded Dec 16, 2025 · filed the same day
An Ultralife director paid $163K out of pocket for Ultralife shares. 3 other people at Ultralife bought some too, in the same month.
Bradford T Whitmore, Director's past purchases, 90 days after disclosure: 9 buys, median −17.0 pts vs S&P 500, beat it 3 of 9 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.